Aehr Test Systems
AEHR
$103.03
+10.41%
Aehr Test Systems designs, manufactures, and markets advanced test and burn-in systems for logic, optical, and memory integrated circuits, operating within the semiconductor capital equipment industry. The company has established itself as a niche leader in burn-in and test solutions, particularly for the high-growth automotive and mobility IC markets where quality and reliability demands are paramount. The current investor narrative is overwhelmingly driven by the company's perceived role in the AI infrastructure build-out, with recent news highlighting major new orders and a surge in bookings, suggesting strong future demand for its specialized equipment to test power components and other semiconductors critical for AI data centers.…
AEHR
Aehr Test Systems
$103.03
Related headlines
Investment Opinion: Should I buy AEHR Today?
Rating: Hold. The core thesis is that AEHR represents a high-risk, high-reward speculation where parabolic price momentum has far outpaced deteriorating fundamentals, creating an asymmetric risk profile skewed to the downside until concrete financial improvement is demonstrated.
Supporting this Hold rating are several critical data points. First, valuation is extreme with an EV/Sales of 79.05, disconnected from the -26.53% YoY revenue decline. Second, profitability is absent, with a TTM net margin of -6.63% and a quarterly operating margin of -49.24%. Third, while bookings news is positive, the company is burning -$11.91M in TTM FCF. Finally, the stock's technicals show it is overextended, trading at 96% of its 52-week high after a 900%+ run, with a beta of 3.271 signaling extreme volatility.
The thesis would upgrade to a Buy only upon confirmation of the revenue inflection, specifically if quarterly revenue sustainably exceeds $25M with gross margins recovering above 35%, and positive operating cash flow is achieved. It would downgrade to a Sell if the next quarter shows continued revenue decline below $9M, cash burn accelerates, or the stock breaks key technical support around $80 on high volume. Based on current data, the stock is grossly overvalued relative to its present fundamentals, though fairly valued relative to the speculative growth expectations embedded in its price.
Sign up to view all
AEHR 12-Month Price Forecast
AEHR is a binary story stock caught between a transformative growth narrative and stark current financial weakness. The neutral stance reflects the high probability (50%) of a base case where reality falls short of dreams, leading to painful multiple compression. The confidence is only medium due to limited analyst coverage and the stock's extreme sensitivity to news flow. The stance would upgrade to bullish only upon seeing two consecutive quarters of revenue growth >50% QoQ with margin expansion. It would turn bearish if the next earnings report shows another sequential revenue decline and increased cash burn, confirming the growth story is faltering.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Aehr Test Systems's 12-month outlook, with a consensus price target around $133.94 and implied upside of +30.0% versus the current price.
Average Target
$133.94
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$82 - $134
Analyst target range
Analyst coverage for AEHR appears to be limited, with data indicating only one analyst providing estimates. The consensus recommendation cannot be determined from a single data point, and an average target price is not provided. The available data shows one analyst estimates an average EPS of $1.14 for the upcoming period, with a range from $1.10 to $1.18, and an average revenue estimate of $196.1 million. This implies a significant projected turnaround from recent losses and revenue declines. The wide dispersion in institutional ratings and recent actions signals high uncertainty and evolving sentiment. Recent actions include an upgrade from William Blair to 'Outperform' from 'Market Perform' in March 2026, which is a bullish signal, while other firms like Craig-Hallum and Freedom Broker have maintained 'Hold' ratings. This mixed picture, coupled with the limited number of covering analysts, is typical for a small-cap, high-volatility stock like AEHR. The lack of broad, consistent analyst coverage can lead to less efficient price discovery and higher volatility, as the stock is more driven by retail sentiment and specific news flow rather than institutional consensus.
Bulls vs Bears: AEHR Investment Factors
The bull case for AEHR is powered almost entirely by forward-looking narrative and momentum—specifically, its perceived critical role in testing AI and automotive semiconductors, backed by a recent surge in bookings. The bear case is grounded in harsh current realities: deteriorating fundamentals, significant cash burn, and a valuation that implies perfection. Currently, the bear side has stronger evidence based on concrete financial data from the last reported quarter. The single most important tension in the investment debate is whether the recent $37M+ in AI-related bookings marks the beginning of a sustained, high-margin revenue inflection that can bridge the vast chasm between its current financials and its sky-high valuation, or if it proves to be a one-time spike insufficient to reverse the trend of declining sales and profits.
Bullish
- Massive AI-Driven Order Momentum: Recent news highlights a $37.2 million surge in new bookings, directly tied to AI data center spending on power component testing. This validates the company's strategic role in a high-growth end-market and provides a strong foundation for future revenue acceleration, countering recent quarterly declines.
- Extreme Technical Momentum and Market Leadership: The stock is up 897.26% over the past year and 227.38% over the past three months, dramatically outperforming the SPY. Trading at 96% of its 52-week high ($121.8), it exhibits powerful momentum, suggesting strong investor conviction in the AI infrastructure narrative and potential for continued upside on positive catalysts.
- Strong Balance Sheet with Minimal Debt: The company has a robust current ratio of 5.68 and a very low debt-to-equity ratio of 0.088. This provides significant financial flexibility to navigate its current unprofitable phase and invest in growth without the overhang of a heavy debt burden, a critical advantage for a small-cap growth story.
- Analyst Projections Signal Major Turnaround: The lone analyst covering AEHR projects average EPS of $1.14 and revenue of $196.1 million for the upcoming period. This implies a massive swing from recent quarterly losses and the -26.53% YoY revenue decline, setting a high benchmark for execution that, if met, could justify the current valuation premium.
Bearish
- Severe Fundamental Deterioration and Cash Burn: Q2 FY2026 revenue declined -26.53% YoY to $9.88M, with a net loss of $3.23M. Gross margin contracted sharply to 25.75% from a TTM 40.59%. Critically, the company burned -$11.91M in TTM free cash flow, indicating it is funding operations by depleting its balance sheet despite the strong liquidity position.
- Extreme Valuation Disconnect from Fundamentals: The stock trades at a trailing PS ratio of 4.79, but an EV/Sales of 79.05, indicating the market is pricing in explosive future growth far beyond current sales. With negative profitability (TTM Net Margin: -6.63%) and declining revenue, this valuation appears speculative and vulnerable to severe compression if growth fails to materialize.
- Parabolic Price Move and High Volatility Risk: The stock has a beta of 3.271, meaning it is over three times as volatile as the market. It has already experienced a -42.31% drawdown from recent highs. Trading near its peak after a 900%+ run, it is highly susceptible to a sharp correction on any disappointment, lack of follow-through orders, or broader market risk-off sentiment.
- Limited Analyst Coverage and High Execution Risk: Only one analyst provides estimates, and institutional ratings are mixed (e.g., William Blair upgrade vs. Craig-Hallum Hold). This lack of consensus and coverage heightens uncertainty and price volatility. The company must execute flawlessly to meet the lofty $196M revenue projection, a steep climb from the $9.88M quarterly run rate.
AEHR Technical Analysis
The stock is in a powerful, sustained uptrend, with a staggering 1-year price change of 897.26% as of the data date. The current price of $116.58 sits at approximately 96% of its 52-week high of $121.8, indicating the stock is trading near its peak and is in a state of extreme momentum, though this also signals potential overextension and vulnerability to a sharp pullback. The stock has experienced a significant drawdown of -42.31% from its recent highs, highlighting its inherent volatility even within the broader uptrend. Recent short-term momentum is exceptionally strong, with the stock up 27.84% over the past month and 227.38% over the past three months, significantly outpacing the broader market (SPY up 4.6% and 12.6% over the same periods). This acceleration from the longer-term trend suggests a parabolic move, likely fueled by specific catalysts like new AI-related orders. The stock's beta of 3.271 indicates it is more than three times as volatile as the market, which is critical for risk assessment and explains the dramatic price swings. Key technical levels are the 52-week high of $121.8 serving as immediate resistance and the 52-week low of $10.89 as a distant support. A decisive breakout above $121.8 could signal a continuation of the parabolic move, while a failure and reversal could trigger a significant correction given the extreme run-up. The stock's high beta of 3.271 underscores its status as a high-risk, high-volatility instrument, meaning position sizing must be managed carefully as price moves are amplified relative to the overall market.
Beta
3.18
3.18x market volatility
Max Drawdown
-42.3%
Largest decline past year
52-Week Range
$11-$122
Price range past year
Annual Return
+785.1%
Cumulative gain past year
| Period | AEHR Return | S&P 500 |
|---|---|---|
| 1m | +6.5% | -0.1% |
| 3m | +188.8% | +11.4% |
| 6m | +320.9% | +8.2% |
| 1y | +785.1% | +22.7% |
| ytd | +364.9% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AEHR Fundamental Analysis
Revenue growth has been volatile and recently negative; the most recent quarterly revenue (Q2 FY2026) was $9.88 million, representing a significant year-over-year decline of -26.53%. This follows a sequential decline from $10.97 million in Q1 and $14.09 million in the prior-year Q4, indicating a concerning deceleration and contraction in the top line. The revenue segment breakdown shows Systems ($6.76M), Contactors ($2.61M), and Services ($1.59M), but without percentage growth data, it's difficult to pinpoint the exact driver of the slowdown, though the Systems segment is the largest contributor. The company is currently unprofitable, with a net loss of $3.23 million in the latest quarter and a trailing twelve-month (TTM) net margin of -6.63%. The gross margin for the quarter was 25.75%, a sharp contraction from the 40.59% TTM gross margin, indicating significant pressure on profitability. The operating margin for the quarter was -49.24%, reflecting high operating expenses relative to the depressed revenue base, and the trend shows margins have deteriorated from the prior quarter's operating margin of -37.07%. The balance sheet shows a strong current ratio of 5.68 and a very low debt-to-equity ratio of 0.088, indicating a healthy liquidity position and minimal financial leverage. However, cash flow is a major concern; the company generated negative free cash flow of -$1.85 million in the latest quarter and -$11.91 million on a TTM basis, meaning it is burning cash to fund operations. The negative return on equity (ROE) of -3.18% and return on assets (ROA) of -6.10% further underscore the company's current lack of profitability and inefficient use of capital.
Quarterly Revenue
$9884000.0B
2025-11
Revenue YoY Growth
-0.26%
YoY Comparison
Gross Margin
+0.25%
Latest Quarter
Free Cash Flow
$-11907000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AEHR Overvalued?
Given the company's negative net income and negative EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 4.79, while the forward-looking metric is not explicitly provided, but the EV/Sales ratio of 79.05 suggests a much higher enterprise value multiple, potentially reflecting market expectations for future revenue growth or strategic value. The significant gap between the PS and EV/Sales ratios warrants further scrutiny into the company's capital structure and cash position. Peer comparison data is not available in the provided dataset, so a sector-relative valuation cannot be quantified. However, the elevated EV/Sales multiple of 79.05, if representative of the industry, suggests the market is pricing in explosive future growth, likely tied to the AI and automotive semiconductor testing narrative. Without industry averages, it is impossible to determine if this premium is justified by superior growth prospects or if it represents speculative excess. Historically, the stock's own PS ratio has fluctuated wildly, reaching as high as 69.83 in late 2025 and as low as 7.77 in mid-2021. The current PS of 4.79 is near the lower end of its recent historical range but still elevated compared to its pre-2024 levels. This positioning suggests the market has tempered some of its most extreme growth expectations from late 2025 but still values the company at a significant premium to its sales, betting on a future revenue inflection. The stock's valuation is highly sensitive to news regarding order flow and end-market demand.
PE
-72.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -111x~168x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-296.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on the company's inability to translate its promising narrative into profitable growth. Revenue declined -26.53% YoY in the latest quarter, and the company is burning cash at a rate of -$11.91M TTM. Gross margin contracted from 40.59% TTM to 25.75% last quarter, indicating significant pricing pressure or product mix issues. The path to the analyst-projected $196M in revenue requires a near 20x sequential quarterly increase, representing extreme execution risk. While the balance sheet is strong now (Current Ratio: 5.68), sustained cash burn will erode this cushion rapidly.
Market & Competitive Risks are amplified by the stock's extreme valuation and volatility. The EV/Sales of 79.05 prices in hyper-growth that may not materialize, leaving the stock vulnerable to multiple compression. Its beta of 3.271 means it will fall precipitously in any market downturn. The stock's narrative is tightly coupled to AI spending cycles; any slowdown in data center capex could immediately reverse the positive sentiment. Furthermore, as a small-cap niche player, AEHR faces competitive risks from larger semiconductor equipment firms that could develop or acquire similar burn-in technology.
Worst-Case Scenario involves the recent AI order surge failing to translate into sustained, profitable revenue growth. A subsequent earnings miss or guidance cut could trigger a rapid derating as momentum investors exit. Given the stock's history of a -42.31% drawdown and its high beta, a return to a more normalized valuation based on current fundamentals (e.g., aligning with its 52-week low of $10.89) is a tangible risk. From the current price of $116.58, this represents a catastrophic downside of approximately -91%. A more realistic, yet still severe, bear-case target could be in the $30-$40 range, representing a -65% to -75% decline, if growth expectations are halved and multiples compress sharply.
FAQ
The key risks are, in order of severity: 1) Valuation & Execution Risk: The stock price assumes hyper-growth that may not materialize; failure to hit revenue targets could cause a -50%+ crash. 2) Financial Deterioration Risk: The company is burning -$11.91M in TTM free cash flow with declining sales and contracting margins, threatening its liquidity runway. 3) Extreme Volatility Risk: With a beta of 3.271, the stock will experience violent swings, having already seen a -42% drawdown recently. 4) Narrative Dependency Risk: The investment thesis is wholly tied to AI spending cycles; any shift in sentiment could collapse the stock regardless of company-specific news.
The 12-month forecast is highly bifurcated with three distinct scenarios. The Base Case (50% probability) sees the stock between $70 and $110 as growth materializes slowly, leading to multiple compression. The Bull Case (25% probability), requiring flawless execution, targets $150 to $200 if the company hits its $196M revenue projection. The Bear Case (25% probability), triggered by continued fundamental decline, sees the stock falling to $30 to $50. The most likely outcome is the Base Case, where the company shows modest improvement but fails to justify its current premium, resulting in a significant price correction from current levels over the medium term.
AEHR is dramatically overvalued based on current fundamentals. The trailing Price-to-Sales ratio of 4.79 is elevated, but the Enterprise Value-to-Sales multiple of 79.05 is astronomical, indicating the market is pricing in explosive future growth far beyond the company's $9.88M quarterly revenue run rate. Compared to its own history, the current PS ratio is near the lower end of its recent wild range (high of 69.83 in late 2025), but this reflects a cooling from peak speculation, not value. The valuation implies the market expects near-perfect execution to achieve the analyst's $196M revenue target, a scenario with low probability given recent trends.
AEHR is not a good buy for most investors at current levels. While the AI-driven narrative is compelling and recent booking news is positive, the stock trades at an extreme valuation (EV/Sales 79.05) after a 900%+ run, completely disconnected from deteriorating fundamentals like a -26.53% revenue decline and significant cash burn. It could be a speculative buy only for investors with a very high risk tolerance, a short-term trading mindset, and the conviction that the company will immediately and dramatically reverse its financial trajectory in the next quarter. For long-term investors seeking fundamentals-based opportunities, it is a clear avoid until proof of execution emerges.
AEHR is unsuitable for traditional long-term investment given its lack of profitability, cash burn, and speculative valuation. Its high beta (3.271) and news-driven price action make it a vehicle for short-term trading or tactical speculation. The suggested minimum holding period is measured in weeks or months, tied directly to earnings cycles and order announcements. Long-term investors should avoid until the company demonstrates at least four consecutive quarters of sustainable revenue growth, margin expansion, and a path to positive free cash flow. Currently, it is purely a trade on the AI narrative, not an investment in a stable business.